Anti-cancer Drugs in Endometriosis Management: Mechanisms and Therapeutic Potential
review
OA: closed
public-domain-us
AI-generated summary
This review examines studies showing that anti-cancer drugs possess therapeutic potential for endometriosis by targeting shared molecular pathways with cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
AI-generated deep summary
This review article examines the therapeutic potential of repurposing anti-cancer drugs for treating endometriosis, based on the premise that the disease shares key malignant features such as uncontrolled growth, angiogenesis, and tissue invasion. The authors analyzed existing cellular, animal, and clinical studies to identify mechanisms by which these oncology agents might inhibit endometriotic lesion progression. While acknowledging significant side effects, the paper highlights the need for further research to optimize dosages and compare these repurposed treatments against conventional therapies in larger clinical trials. This paper is centrally about endometriosis — specifically exploring the mechanistic parallels between cancer biology and endometriosis to evaluate novel pharmacological interventions.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
INTRODUCTION: Endometriosis is a widespread estrogen-driven condition causing pelvic pain and infertility in women. This disease shares five features with cancer: Intrinsic growth signals, insensitivity to antiproliferative signals, impaired apoptosis, induction of angiogenesis, and heightened tissue invasion, suggesting common therapeutic targets for both conditions. This article reviews studies investigating the anti-cancer drugs' protective effects and mechanisms in endometriosis treatment, providing essential insights into their efficacy and the relevant pathways in managing the disease.
METHODS: A comprehensive review was conducted to assess the potential therapeutic benefits of anti-cancer drugs in endometriosis treatment. This included an extensive search of Google Scholar and PubMed, using relevant keywords without any limitations until the end of 2024, to ensure a thorough analysis of existing research in this field.
RESULTS: Many drugs used in treating estrogen-dependent and other cancers have demonstrated significant therapeutic potential for endometriosis, as supported by cellular, animal, and clinical studies.
DISCUSSION: Though these drugs may have significant side effects, more research is necessary to determine their usefulness in endometriosis treatment. By studying various drug dosages and regimens, researchers can aim to achieve effective treatment with minimal side effects. Personalized treatment based on illness severity can be achieved by selecting the right medication and dosage.
CONCLUSION: Future research can include optimizing dosages in preclinical studies, comparing repurposed drugs to conventional therapies in randomized trials, and conducting longer and larger clinical trials further to assess side effects and effectiveness in endometriosis patients.
Full text
11,813 characters
· extracted from
oa-doi-fallback
· 6 sections
· click to expand
Abstract
Introduction: Endometriosis is a widespread estrogen-driven condition causing pelvic pain and infertility in women. This disease shares five features with cancer: Intrinsic growth signals, insensitivity to antiproliferative signals, impaired apoptosis, induction of angiogenesis, and heightened tissue invasion, suggesting common therapeutic targets for both conditions. This article reviews studies investigating the anti-cancer drugs' protective effects and mechanisms in endometriosis treatment, providing essential insights into their efficacy and the relevant pathways in managing the disease.
Methods
A comprehensive review was conducted to assess the potential therapeutic benefits of anti-cancer drugs in endometriosis treatment. This included an extensive search of Google Scholar and PubMed, using relevant keywords without any limitations until the end of 2024, to ensure a thorough analysis of existing research in this field.
Results
Many drugs used in treating estrogen-dependent and other cancers have demonstrated significant therapeutic potential for endometriosis, as supported by cellular, animal, and clinical studies.
Discussion
Though these drugs may have significant side effects, more research is necessary to determine their usefulness in endometriosis treatment. By studying various drug dosages and regimens, researchers can aim to achieve effective treatment with minimal side effects. Personalized treatment based on illness severity can be achieved by selecting the right medication and dosage.
Conclusion
Future research can include optimizing dosages in preclinical studies, comparing repurposed drugs to conventional therapies in randomized trials, and conducting longer and larger clinical trials further to assess side effects and effectiveness in endometriosis patients.
Keywords
Endometriosis, estrogen, tumor, malignancy, proliferation, pelvic pain, infertility
[http://dx.doi.org/10.1155/2022/6042518] [PMID: 35837295]
[http://dx.doi.org/10.3389/fimmu.2020.599117] [PMID: 33505394]
[http://dx.doi.org/10.1002/jcph.846] [PMID: 27925651]
[http://dx.doi.org/10.1016/j.fertnstert.2007.03.069] [PMID: 17498711]
[http://dx.doi.org/10.1093/humupd/dmt027] [PMID: 23884896]
[http://dx.doi.org/10.12688/f1000research.14817.1] [PMID: 31069056]
[http://dx.doi.org/10.4103/0974-2727.66699] [PMID: 21814398]
[http://dx.doi.org/10.3389/fimmu.2023.1128301] [PMID: 37138868]
[http://dx.doi.org/10.3390/cells11132028] [PMID: 35805112]
[http://dx.doi.org/10.1016/j.fertnstert.2023.03.021] [PMID: 36963717]
[http://dx.doi.org/10.1111/j.1440-172X.2008.00718.x] [PMID: 19126072]
[http://dx.doi.org/10.1055/s-2008-1068753] [PMID: 9383832]
[http://dx.doi.org/10.3390/ijms221910554] [PMID: 34638893]
[http://dx.doi.org/10.1080/09513590802296062] [PMID: 19012093]
[http://dx.doi.org/10.1530/RAF-21-0106] [PMID: 35514542]
[http://dx.doi.org/10.3390/ijms25116266] [PMID: 38892453]
[http://dx.doi.org/10.3390/cells10030677] [PMID: 33803806]
[http://dx.doi.org/10.1210/jc.2003-031406] [PMID: 15001592]
[http://dx.doi.org/10.1016/j.mayocp.2019.10.001] [PMID: 31806110]
[http://dx.doi.org/10.3390/ijms22115998] [PMID: 34206129]
[http://dx.doi.org/10.1371/journal.pone.0163540] [PMID: 27695098]
[http://dx.doi.org/10.1002/jcp.28666] [PMID: 31004368]
[http://dx.doi.org/10.3390/jcm10245879] [PMID: 34945174]
[http://dx.doi.org/10.3390/ijms241411741] [PMID: 37511500]
[PMID: 11208452]
[http://dx.doi.org/10.1093/humrep/17.2.426] [PMID: 11821289]
[http://dx.doi.org/10.1634/theoncologist.2016-0197] [PMID: 27807302]
[http://dx.doi.org/10.1159/000201388] [PMID: 8813462]
[PMID: 19846910]
[http://dx.doi.org/10.1093/jnci/94.4.252] [PMID: 11854387]
[http://dx.doi.org/10.1136/bmj.320.7250.1642] [PMID: 10856067]
[http://dx.doi.org/10.1016/j.ejps.2013.05.021] [PMID: 23747661]
[http://dx.doi.org/10.3389/fendo.2022.1034614] [PMID: 36743927]
[http://dx.doi.org/10.7717/peerj.11664] [PMID: 34249506]
[http://dx.doi.org/10.3390/ijms131013240] [PMID: 23202950]
[PMID: 20677482]
[http://dx.doi.org/10.1093/oxfordjournals.humrep.a135790] [PMID: 8567812]
[http://dx.doi.org/10.1007/s43032-020-00383-4] [PMID: 33216295]
[http://dx.doi.org/10.3389/fimmu.2022.961599] [PMID: 36016927]
[http://dx.doi.org/10.3390/ijms25063362] [PMID: 38542336]
[http://dx.doi.org/10.1080/13543784.2022.2152325] [PMID: 36529967]
[http://dx.doi.org/10.3390/ijms20153822] [PMID: 31387263]
[http://dx.doi.org/10.3390/jcm8091468] [PMID: 31540116]
[http://dx.doi.org/10.1210/jc.85.8.2897] [PMID: 10946900]
[http://dx.doi.org/10.1677/jme.0.0250035] [PMID: 10915216]
[http://dx.doi.org/10.1016/S0015-0282(00)01522-3] [PMID: 11020520]
[http://dx.doi.org/10.1530/rep.0.1230217] [PMID: 11866688]
[http://dx.doi.org/10.1210/me.2008-0322] [PMID: 18818281]
[http://dx.doi.org/10.1016/S0093-7754(02)70065-1] [PMID: 12516034]
[http://dx.doi.org/10.1590/1806-9282.63.04.371] [PMID: 28614542]
[http://dx.doi.org/10.1016/j.fertnstert.2005.02.018] [PMID: 16084868]
[http://dx.doi.org/10.1200/JCO.2001.19.3.881] [PMID: 11157042]
[http://dx.doi.org/10.1186/s12905-021-01347-9] [PMID: 34016111]
[http://dx.doi.org/10.1093/humupd/6.5.413] [PMID: 11045871]
[http://dx.doi.org/10.1016/j.fertnstert.2006.11.188] [PMID: 17336977]
[http://dx.doi.org/10.1016/j.jri.2009.11.004] [PMID: 20074813]
[http://dx.doi.org/10.1007/s00281-007-0077-0] [PMID: 17621704]
[http://dx.doi.org/10.1007/s40261-020-00901-x] [PMID: 32162237]
[http://dx.doi.org/10.1016/j.fertnstert.2005.04.059] [PMID: 16213868]
[http://dx.doi.org/10.1016/j.ejogrb.2010.02.004] [PMID: 20188455]
[http://dx.doi.org/10.1016/j.fertnstert.2009.09.031] [PMID: 20045515]
[http://dx.doi.org/10.1517/17425250903540246] [PMID: 20095792]
[http://dx.doi.org/10.1007/s10549-010-1091-9] [PMID: 20821047]
[http://dx.doi.org/10.1016/j.fertnstert.2005.09.064] [PMID: 16647373]
[http://dx.doi.org/10.1016/j.mefs.2013.04.007]
[http://dx.doi.org/10.1111/j.1600-0412.2011.01346.x] [PMID: 22181973]
[http://dx.doi.org/10.1080/01443615.2021.1904224] [PMID: 34020578]
[http://dx.doi.org/10.1016/j.fertnstert.2003.09.029] [PMID: 14967362]
[http://dx.doi.org/10.22074/ijfs.2010.45826]
[PMID: 25664308]
[http://dx.doi.org/10.12688/f1000research.141510.1]
[http://dx.doi.org/10.1186/s43043-023-00153-7]
[http://dx.doi.org/10.1155/2021/9946060] [PMID: 34901283]
[PMID: 28742263]
[http://dx.doi.org/10.1016/j.ejca.2018.03.020] [PMID: 29679775]
[http://dx.doi.org/10.2147/DDDT.S315726] [PMID: 37168488]
[http://dx.doi.org/10.1586/14737140.5.4.591] [PMID: 16111461]
[http://dx.doi.org/10.1016/S0015-0282(98)00086-7] [PMID: 9627292]
[http://dx.doi.org/10.1016/S0015-0282(16)57837-6] [PMID: 7672133]
[http://dx.doi.org/10.1093/humrep/deh035] [PMID: 14688176]
[http://dx.doi.org/10.1016/j.xfre.2022.11.009] [PMID: 37223763]
[http://dx.doi.org/10.6039/j.issn.1001-0408.2024.14.13]
[http://dx.doi.org/10.1186/s12884-024-06430-1] [PMID: 38575880]
[http://dx.doi.org/10.1177/22840265211018310]
[http://dx.doi.org/10.1097/00002281-200107000-00016] [PMID: 11555738]
[PMID: 12598839]
[http://dx.doi.org/10.1093/humupd/6.3.212] [PMID: 10874566]
[http://dx.doi.org/10.1093/humrep/15.suppl_3.30] [PMID: 11041219]
[http://dx.doi.org/10.1097/01.AOG.0000297307.35024.b5] [PMID: 18165396]
[http://dx.doi.org/10.6118/jmm.2016.22.3.174] [PMID: 28119898]
[http://dx.doi.org/10.3390/ijms222111342] [PMID: 34768770]
[http://dx.doi.org/10.1089/152460902753668484] [PMID: 11988138]
[http://dx.doi.org/10.1007/s43032-020-00213-7] [PMID: 32542537]
[http://dx.doi.org/10.1371/journal.pone.0166658] [PMID: 27855197]
[http://dx.doi.org/10.3389/fsurg.2021.791686] [PMID: 34938768]
[http://dx.doi.org/10.3389/fphar.2019.00426] [PMID: 31105567]
[http://dx.doi.org/10.1016/S1470-2045(17)30279-6] [PMID: 28438473]
[http://dx.doi.org/10.2146/ajhp080455] [PMID: 19451611]
[http://dx.doi.org/10.1016/S0026-895X(25)13597-9] [PMID: 8429822]
[http://dx.doi.org/10.1006/bcmd.2000.0298] [PMID: 10950941]
[http://dx.doi.org/10.1215/15228517-4-1-22] [PMID: 11772429]
[http://dx.doi.org/10.1097/SHK.0b013e3181a7fd74] [PMID: 19373131]
[http://dx.doi.org/10.1189/jlb.71.1.9] [PMID: 11781376]
[http://dx.doi.org/10.1093/emboj/20.24.7108] [PMID: 11742987]
[PMID: 17310834]
[http://dx.doi.org/10.1007/BF01420190] [PMID: 2360465]
[http://dx.doi.org/10.3923/ijp.2014.267.274]
[http://dx.doi.org/10.1097/00008390-200512000-00014] [PMID: 16314745]
[http://dx.doi.org/10.7150/ijbs.60167] [PMID: 34326686]
[http://dx.doi.org/10.3892/or.2016.4804] [PMID: 27177074]
[http://dx.doi.org/10.3389/fphar.2018.00811] [PMID: 30093862]
[http://dx.doi.org/10.1016/j.lfs.2023.121921] [PMID: 37429417]
[http://dx.doi.org/10.1016/j.jri.2023.103967] [PMID: 37229887]
[http://dx.doi.org/10.1016/j.jri.2023.103814] [PMID: 36773495]
[http://dx.doi.org/10.1046/j.1365-2141.2001.03166.x] [PMID: 11843813]
[http://dx.doi.org/10.1136/ard.61.10.883] [PMID: 12228157]
[http://dx.doi.org/10.1093/rheumatology/40.2.205] [PMID: 11257159]
[http://dx.doi.org/10.1056/NEJMoa032534] [PMID: 15201414]
[http://dx.doi.org/10.3892/ol.2018.9275] [PMID: 30250597]
[http://dx.doi.org/10.2165/00003495-200464110-00005] [PMID: 15161328]
[http://dx.doi.org/10.1016/j.ejps.2016.07.018] [PMID: 27481456]
[http://dx.doi.org/10.5812/nephropathol.8122] [PMID: 24475415]
[http://dx.doi.org/10.1016/j.mrgentox.2004.08.010] [PMID: 15507376]
[http://dx.doi.org/10.1080/01485010150211146] [PMID: 11204616]
[http://dx.doi.org/10.1016/0959-8049(95)00047-M] [PMID: 7640048]
[http://dx.doi.org/10.1016/S0015-0282(97)81465-3] [PMID: 9207575]
[http://dx.doi.org/10.1002/j.1939-4640.2005.tb02883.x] [PMID: 15611578]
[http://dx.doi.org/10.1002/jat.1284] [PMID: 17604343]
[http://dx.doi.org/10.5301/jn.5000018] [PMID: 21928232]
[http://dx.doi.org/10.1016/j.etap.2008.01.006] [PMID: 21783887]
[http://dx.doi.org/10.1007/s00280-007-0459-y] [PMID: 17396264]
[http://dx.doi.org/10.1007/s00204-006-0173-2] [PMID: 17216432]
[http://dx.doi.org/10.1039/C8DT00838H] [PMID: 29632935]
[http://dx.doi.org/10.3389/fimmu.2021.641206] [PMID: 34367125]
[http://dx.doi.org/10.3109/01443615.2014.941345] [PMID: 25093747]
[http://dx.doi.org/10.1038/nrd2380] [PMID: 17690708]
[http://dx.doi.org/10.1002/jcla.23482] [PMID: 32761670]
[http://dx.doi.org/10.1007/s10456-012-9299-4] [PMID: 22948799]
[PMID: 17331421]
[http://dx.doi.org/10.1111/j.1600-0897.2011.01101.x] [PMID: 22229383]
[PMID: 25550812]
[http://dx.doi.org/10.1177/1933719115584448] [PMID: 25963915]
[http://dx.doi.org/10.1158/1535-7163.MCT-10-1124] [PMID: 22161785]
[http://dx.doi.org/10.1177/1933719112452941] [PMID: 22895024]
[http://dx.doi.org/10.1042/BSR20200199] [PMID: 33245099]
[http://dx.doi.org/10.4103/0973-1482.147378] [PMID: 26148617]
[http://dx.doi.org/10.1080/21691401.2019.1653900] [PMID: 31432702]
[http://dx.doi.org/10.1021/acs.jmedchem.7b01096] [PMID: 29424539]
[http://dx.doi.org/10.3892/mmr.2017.6740] [PMID: 28627615]
[http://dx.doi.org/10.5582/ddt.8.33] [PMID: 24647156]
[http://dx.doi.org/10.1016/j.ejmech.2017.04.025] [PMID: 28431353]
[http://dx.doi.org/10.1021/acs.jmedchem.5b01203] [PMID: 26891099]
[http://dx.doi.org/10.31083/j.ceog5008164]
[http://dx.doi.org/10.1080/13880209.2023.2195883] [PMID: 37095705]
[http://dx.doi.org/10.1155/2016/3595946] [PMID: 27738442]
[http://dx.doi.org/10.1016/j.gsd.2024.101103]
[http://dx.doi.org/10.1007/s00467-002-0946-7] [PMID: 12376811]
[http://dx.doi.org/10.1016/j.jenvman.2020.111448] [PMID: 33254841]
[http://dx.doi.org/10.1016/j.chemosphere.2015.07.069] [PMID: 26298026]
[http://dx.doi.org/10.1007/s00404-023-07246-8] [PMID: 37987824]
[http://dx.doi.org/10.3310/hta4400] [PMID: 11207450]
[http://dx.doi.org/10.1046/j.1468-3083.2001.t01-1-00223.x] [PMID: 11683290]
[http://dx.doi.org/10.1001/archderm.1996.03890260086013] [PMID: 8629827]
[http://dx.doi.org/10.1111/j.1365-2133.1995.tb02637.x] [PMID: 7547406]
[http://dx.doi.org/10.7759/cureus.29518] [PMID: 36312688]
[http://dx.doi.org/10.1016/S0190-9622(88)80237-8] [PMID: 3042816]
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-09-28T06:13:43.407401+00:00
- pubmed
- last seen: 2026-09-29T06:13:17.136108+00:00
- unpaywall
- last seen: 2026-09-28T06:20:55.906821+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine